SWHR Policy Advisory Council Meeting
Virtual MeetingSWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]
SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]
The Office of Research on Women’s Health (ORWH) is pleased to announce a new program, Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) R25 (RFA-OD-22-015). The […]
SWHR hosted a webinar to share educational information about narcolepsy, including diagnosing, treating, and managing care, and to highlight the experiences of women living with narcolepsy.
During this SWHR town hall event, heard from speakers about how individuals across communities can take steps to prepare for Alzheimer's and how organizations and policymakers alike are taking steps to improve Alzheimer's outcomes and reach diverse and underserved communities.
SWHR’s Policy Advisory Council will meet for its quarterly closed-door meeting. The Policy Advisory Council is a forum for industry, […]
During this virtual congressional briefing and national webinar, panelists reviewed ethical considerations surrounding inclusion of pregnant and lactating women in research, how to ensure the appropriate inclusion of these populations, and the current state of this type of inclusion in research, both within the federal government and the corporate sector.
During this public forum, panelists discussed the disproportionate impact of autoimmune diseases and conditions on women and why tackling autoimmune diseases and conditions should be a federal priority. Following the discussion, panelists also reviewed SWHR’s newly launched autoimmune disease policy agenda.
The Friends of the Office of Research on Women’s Health invite you to a congressional reception in celebration of Women’s […]
During this congressional briefing and national webinar, panelists explored certain areas of research where the exclusion of these groups has resulted in an inability to support them, how federal research investments could improve outcomes, and where there is opportunity—both at the legislative and regulatory level—moving forward.
In this webinar, panelists reviewed coverage and access issues that could negatively affect those with autoimmune diseases and conditions, the tenants of prior authorization and step therapy, discuss the role these policies can play in patient outcomes and on providers, and how current policies could be modified to better serve individuals.